March 28, 2023

ATA Action's Letter to the DEA Re: Expansion of Induction of Buprenorphine via Telemedicine Encounter

ATA Action Letter

ATA Action submitted comments in response to the Drug Enforcement Administration (DEA)’s proposed rules regarding expansion of induction of buprenorphine via telemedicine